Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph Chewning

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Bioorganic & Medicinal Chemistry Letters|January 29, 2013
Pharmacological properties and predicted binding mode of arylmethylene quinuclidine-like derivatives at the α3β4 nicotinic acetylcholine receptor (nAChR)David C Kombo, Terry A Hauser, Vladimir P Grinevich, et al.
Blood|November 18, 2020
A validated pediatric disease risk index for allogeneic hematopoietic cell transplantationMuna Qayed, Kwang Woo Ahn, Carrie L Kitko, et al.
Haematologica|June 20, 2020
Comparison of total body irradiation <i>versus</i> non-total body irradiation containing regimens for de novo acute myeloid leukemia in childrenChristopher E Dandoy, Stella M Davies, Kwang Woo Ahn, et al.
Transplantation and Cellular Therapy|April 26, 2026
Eculizumab for Pediatric Hematopoietic Cell Transplant Associated Thrombotic Microangiopathy: Real World Response Rates, Predictors of Poor Response, and an Optimal Timepoint for Treatment Response AssessmentMichelle L Schoettler, Geoffrey Cheng, Christine S Higham, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 13, 2018
Treosulfan, Fludarabine, and Low-Dose Total Body Irradiation for Children and Young Adults with Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Allogeneic Hematopoietic Cell Transplantation: Prospective Phase II Trial of the Pediatric Blood and Marrow Transplant ConsortiumEneida R Nemecek, Ralf A Hilger, Alexia Adams, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Bioorganic & Medicinal Chemistry Letters|January 29, 2013
Pharmacological properties and predicted binding mode of arylmethylene quinuclidine-like derivatives at the α3β4 nicotinic acetylcholine receptor (nAChR)David C Kombo, Terry A Hauser, Vladimir P Grinevich, et al.
Blood|November 18, 2020
A validated pediatric disease risk index for allogeneic hematopoietic cell transplantationMuna Qayed, Kwang Woo Ahn, Carrie L Kitko, et al.
Haematologica|June 20, 2020
Comparison of total body irradiation <i>versus</i> non-total body irradiation containing regimens for de novo acute myeloid leukemia in childrenChristopher E Dandoy, Stella M Davies, Kwang Woo Ahn, et al.
Transplantation and Cellular Therapy|April 26, 2026
Eculizumab for Pediatric Hematopoietic Cell Transplant Associated Thrombotic Microangiopathy: Real World Response Rates, Predictors of Poor Response, and an Optimal Timepoint for Treatment Response AssessmentMichelle L Schoettler, Geoffrey Cheng, Christine S Higham, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 13, 2018
Treosulfan, Fludarabine, and Low-Dose Total Body Irradiation for Children and Young Adults with Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Allogeneic Hematopoietic Cell Transplantation: Prospective Phase II Trial of the Pediatric Blood and Marrow Transplant ConsortiumEneida R Nemecek, Ralf A Hilger, Alexia Adams, et al.
Pageof 2